Thomas A Waldmann Selected Research

Thomas A Waldmann Research Topics

Disease

91	Neoplasms (Cancer) 10/2022 - 02/2002
32	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2022 - 02/2002
27	Lymphoma (Lymphomas) 01/2021 - 02/2002
19	Leukemia 10/2019 - 02/2002
12	T-Cell Leukemia (Leukemia, T Cell) 01/2017 - 02/2002
11	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2003
8	Infections 01/2021 - 11/2007
8	Multiple Sclerosis 10/2019 - 06/2004
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 02/2002
7	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 10/2015
6	Celiac Disease (Celiac Sprue) 01/2020 - 01/2006
6	Melanoma (Melanoma, Malignant) 01/2019 - 01/2014
6	Inflammation (Inflammations) 11/2014 - 09/2008
6	Vaccinia 04/2014 - 03/2003
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 06/2012
4	Uveitis 01/2019 - 11/2003
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017 - 12/2003
4	Rheumatoid Arthritis 10/2015 - 09/2005
4	Breast Neoplasms (Breast Cancer) 11/2014 - 05/2004
4	Smallpox (Variola) 10/2010 - 01/2007
3	Hematologic Neoplasms (Hematological Malignancy) 10/2019 - 11/2005
3	Large Granular Lymphocytic Leukemia 01/2019 - 01/2006
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2015
3	Human Influenza (Influenza) 01/2018 - 07/2005
3	Carcinoma (Carcinomatosis) 12/2010 - 01/2005
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2020 - 10/2015
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 12/2018
2	Atrophy 01/2020 - 09/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2006
2	Hairy Cell Leukemia 12/2018 - 11/2004
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 12/2003
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2013 - 01/2007
2	Disease Progression 10/2011 - 04/2009
2	Encephalitis (Encephalitis, Rasmussen) 05/2011 - 04/2006

Drug/Important Bio-Agent (IBA)

57	Interleukin-15 (Interleukin 15)IBA 04/2022 - 01/2003
32	Monoclonal AntibodiesIBA 01/2022 - 02/2002
25	CytokinesIBA 01/2021 - 01/2006
19	Interleukin-2 (IL2)IBA 01/2021 - 03/2002
18	VaccinesIBA 01/2019 - 03/2003
15	AntibodiesIBA 01/2022 - 08/2004
13	Daclizumab (Zenapax)FDA Link 05/2020 - 11/2003
11	Alemtuzumab (Campath)FDA Link 04/2022 - 10/2003
10	AntigensIBA 05/2020 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2002
8	Interleukin-2 Receptors (IL 2 Receptor)IBA 11/2018 - 02/2002
7	Pharmaceutical PreparationsIBA 12/2022 - 11/2004
4	Phosphotransferases (Kinase)IBA 11/2020 - 01/2017
4	Interleukin-9 (Interleukin 9)IBA 01/2020 - 05/2008
4	Rituximab (Mabthera)FDA Link 01/2020 - 04/2008
4	Radioisotopes (Radionuclides)IBA 02/2008 - 07/2002
4	Interleukin-2 Receptor alpha SubunitIBA 08/2006 - 07/2002
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2020 - 02/2004
3	Immune Checkpoint InhibitorsIBA 10/2019 - 12/2015
3	siplizumabIBA 01/2018 - 07/2003
3	Cytokine Receptors (Cytokine Receptor)IBA 11/2017 - 12/2013
3	Janus Kinase InhibitorsIBA 11/2017 - 04/2013
3	navitoclaxIBA 01/2017 - 10/2015
3	tofacitinibIBA 10/2015 - 02/2011
3	Glycoproteins (Glycoprotein)IBA 12/2014 - 02/2002
3	DNA VaccinesIBA 11/2014 - 07/2005
3	Therapeutic UsesIBA 03/2012 - 05/2004
3	Fc Receptors (Fc Receptor)IBA 07/2006 - 10/2003
3	Dendrimers (Dendrons)IBA 11/2005 - 04/2004
3	Contrast MediaIBA 11/2004 - 04/2004
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2022 - 01/2021
2	Trans-Activators (Trans-Acting Factor)IBA 01/2021 - 10/2015
2	LigandsIBA 01/2021 - 01/2020
2	obinutuzumabIBA 01/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2016
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
2	avelumabIBA 01/2021 - 01/2020
2	UbiquitinIBA 11/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 05/2020 - 01/2019
2	Brentuximab VedotinIBA 01/2020 - 02/2016
2	NivolumabIBA 01/2020 - 10/2019
2	InterleukinsIBA 01/2020 - 12/2018
2	IpilimumabIBA 01/2020 - 02/2007
2	interleukin-21 (interleukin 21)IBA 01/2020 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 04/2016
2	NF-kappa B (NF-kB)IBA 06/2019 - 02/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2016
2	InterferonsIBA 12/2018 - 06/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 11/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 12/2010
2	Anaplastic Lymphoma KinaseIBA 11/2017 - 11/2004
2	ruxolitinibIBA 02/2016 - 10/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2014 - 09/2007
2	LipidsIBA 12/2014 - 07/2004
2	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2014 - 03/2009
2	Glutens (Glutelin)IBA 04/2013 - 09/2009
2	B7-H1 AntigenIBA 04/2012 - 12/2010
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2012 - 07/2005
2	CTLA-4 AntigenIBA 04/2012 - 12/2010

Therapy/Procedure

48	Therapeutics 12/2022 - 10/2002
16	Immunotherapy 01/2022 - 07/2002
6	Drug Therapy (Chemotherapy) 01/2021 - 10/2011
6	Radioimmunotherapy 06/2009 - 07/2002
3	Intravenous Infusions 01/2019 - 12/2014
3	Radiotherapy 08/2012 - 02/2003
2	Immunomodulation 01/2019 - 01/2006